002562 Stock Overview
Engages in the research and development, production, and sale of leather chemicals in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Brother Enterprises Holding Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.42 |
| 52 Week High | CN¥5.43 |
| 52 Week Low | CN¥2.51 |
| Beta | 0.34 |
| 11 Month Change | -7.72% |
| 3 Month Change | 33.94% |
| 1 Year Change | 9.95% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -15.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002562 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -2.2% | -3.2% | -2.6% |
| 1Y | 10.0% | -3.5% | 4.2% |
Return vs Industry: 002562 exceeded the CN Chemicals industry which returned -3.7% over the past year.
Return vs Market: 002562 exceeded the CN Market which returned 4.6% over the past year.
Price Volatility
| 002562 volatility | |
|---|---|
| 002562 Average Weekly Movement | 8.2% |
| Chemicals Industry Average Movement | 8.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002562 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002562's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 3,052 | Jianping Li | www.brother.com.cn |
Brother Enterprises Holding Co.,Ltd. engages in the research and development, production, and sale of leather chemicals in China and internationally. It operates in six segments: Vitamins, Spices, Active Pharmaceutical Ingredients, Leather Chemicals, Chrome Salt, and Catalyst.
Brother Enterprises Holding Co.,Ltd. Fundamentals Summary
| 002562 fundamental statistics | |
|---|---|
| Market cap | CN¥4.70b |
| Earnings (TTM) | -CN¥145.57m |
| Revenue (TTM) | CN¥3.26b |
1.4x
P/S Ratio-32.3x
P/E RatioIs 002562 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002562 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.26b |
| Cost of Revenue | CN¥2.91b |
| Gross Profit | CN¥354.29m |
| Other Expenses | CN¥499.86m |
| Earnings | -CN¥145.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 10.86% |
| Net Profit Margin | -4.46% |
| Debt/Equity Ratio | 53.3% |
How did 002562 perform over the long term?
See historical performance and comparison